Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James G Ryall

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Current Opinion in Clinical Nutrition and Metabolic Care|September 11, 2009
The role of beta-adrenoceptor signaling in skeletal muscle: therapeutic implications for muscle wasting disordersRené Koopman, James G Ryall, Jarrod E Church, et al.
Experimental Physiology|June 24, 2008
Insulin-like growth factor-I analogue protects muscles of dystrophic mdx mice from contraction-mediated damageStefan M Gehrig, James G Ryall, Jonathan D Schertzer, et al.
The American Journal of Pathology|September 8, 2007
Modulation of insulin-like growth factor (IGF)-I and IGF-binding protein interactions enhances skeletal muscle regeneration and ameliorates the dystrophic pathology in mdx miceJonathan D Schertzer, Stefan M Gehrig, James G Ryall, et al.
BMC Genomics|September 24, 2009
Expression profiling of skeletal muscle following acute and chronic beta2-adrenergic stimulation: implications for hypertrophy, metabolism and circadian rhythmMichael A Pearen, James G Ryall, Gordon S Lynch, et al.
Frontiers in Cell and Developmental Biology|November 19, 2019
The Microenvironment Is a Critical Regulator of Muscle Stem Cell Activation and ProliferationJohn H Nguyen, Jin D Chung, Gordon S Lynch, et al.
Neuromuscular Disorders : NMD|December 1, 2006
Low dose formoterol administration improves muscle function in dystrophic mdx mice without increasing fatigueLeah J Harcourt, Jonathan D Schertzer, James G Ryall, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|January 29, 2011
Acute antibody-directed myostatin inhibition attenuates disuse muscle atrophy and weakness in miceKate T Murphy, Vera Cobani, James G Ryall, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|October 22, 2002
Beta 2-agonist fenoterol has greater effects on contractile function of rat skeletal muscles than clenbuterolJames G Ryall, Paul Gregorevic, David R Plant, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 1, 2005
Chronic beta-agonist administration affects cardiac function of adult but not old rats, independent of beta-adrenoceptor densityPaul Gregorevic, James G Ryall, David R Plant, et al.
The Journal of Physiology|November 18, 2003
Beta 2-agonist administration reverses muscle wasting and improves muscle function in aged ratsJames G Ryall, David R Plant, Paul Gregorevic, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Current Opinion in Clinical Nutrition and Metabolic Care|September 11, 2009
The role of beta-adrenoceptor signaling in skeletal muscle: therapeutic implications for muscle wasting disordersRené Koopman, James G Ryall, Jarrod E Church, et al.
Experimental Physiology|June 24, 2008
Insulin-like growth factor-I analogue protects muscles of dystrophic mdx mice from contraction-mediated damageStefan M Gehrig, James G Ryall, Jonathan D Schertzer, et al.
The American Journal of Pathology|September 8, 2007
Modulation of insulin-like growth factor (IGF)-I and IGF-binding protein interactions enhances skeletal muscle regeneration and ameliorates the dystrophic pathology in mdx miceJonathan D Schertzer, Stefan M Gehrig, James G Ryall, et al.
BMC Genomics|September 24, 2009
Expression profiling of skeletal muscle following acute and chronic beta2-adrenergic stimulation: implications for hypertrophy, metabolism and circadian rhythmMichael A Pearen, James G Ryall, Gordon S Lynch, et al.
Frontiers in Cell and Developmental Biology|November 19, 2019
The Microenvironment Is a Critical Regulator of Muscle Stem Cell Activation and ProliferationJohn H Nguyen, Jin D Chung, Gordon S Lynch, et al.
Neuromuscular Disorders : NMD|December 1, 2006
Low dose formoterol administration improves muscle function in dystrophic mdx mice without increasing fatigueLeah J Harcourt, Jonathan D Schertzer, James G Ryall, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|January 29, 2011
Acute antibody-directed myostatin inhibition attenuates disuse muscle atrophy and weakness in miceKate T Murphy, Vera Cobani, James G Ryall, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|October 22, 2002
Beta 2-agonist fenoterol has greater effects on contractile function of rat skeletal muscles than clenbuterolJames G Ryall, Paul Gregorevic, David R Plant, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 1, 2005
Chronic beta-agonist administration affects cardiac function of adult but not old rats, independent of beta-adrenoceptor densityPaul Gregorevic, James G Ryall, David R Plant, et al.
The Journal of Physiology|November 18, 2003
Beta 2-agonist administration reverses muscle wasting and improves muscle function in aged ratsJames G Ryall, David R Plant, Paul Gregorevic, et al.
Pageof 6